https://orcid.org/0000-0002-2118-0499
References
- Fuchs FD, Whelton PK. High blood pressure and cardiovascular disease. Hypertension. 2020;75(2):285–292. doi:10.1161/HYPERTENSIONAHA.119.14240
- Reiter R, Paredes S, Korkmaz A, Manchester L, Tan D. Melatonin in relation to the ”strong” and ”weak” versions of the free radical theory of aging. Adv Med Sci. 2008;53(2):119. doi:10.2478/v10039-008-0032-x
- Sun N. Melatonin supplementation for blood pressure control: a systematic review and meta-analysis of randomized controlled trials. J Hum Hypertens. 2020;34(1):13–21.
- Simko F, Bednarova KR, Krajcirovicova K, et al. Melatonin reduces cardiac remodeling and improves survival in rats with isoproterenol‐induced heart failure. J Pineal Res. 2014;57(2):177–184. doi:10.1111/jpi.12154
- Özsan M. Sleep and melatonin. At International Conference on Modern and Advanced Research; July 29–31; 2023; Konya, Turkey.
- Cipolla-Neto J, Amaral FG. Melatonin as a hormone: new physiological and clinical insights. Endocr Rev. 2018;39(6):990–1028. doi:10.1210/er.2018-00084
- Pechanova O, Paulis L, Simko F. Peripheral and central effects of melatonin on blood pressure regulation. Int J Mol Sci. 2014;15(10):17920–17937. doi:10.3390/ijms151017920
- Chitimus DM, Popescu MR, Voiculescu SE, et al. Melatonin’s impact on antioxidative and anti-inflammatory reprogramming in homeostasis and disease. Biomolecules. 2020;10(9):1211. doi:10.3390/biom10091211
- The National Library of Medicine. NCT00238108; 2010. Available from: https://clinicaltrials.gov/study/NCT00238108. Accessed January 31, 2024.
- The National Library of Medicine. NCT01114373; 2014. Available from: https://clinicaltrials.gov/study/NCT01114373. Accessed January 31, 2024.
- The National Library of Medicine. NCT01114360; 2014. Available from: https://clinicaltrials.gov/study/NCT01114360. Accessed January 31, 2024.
- Lee EKP, Poon P, Yu CP, Lee VWY, Chung VCH, Wong SYS. Controlled‐release oral melatonin supplementation for hypertension and nocturnal hypertension: a systematic review and meta‐analysis. J Clin Hypertens. 2022;24(5):529–535. doi:10.1111/jch.14482
- Canoy D, Nazarzadeh M, Copland E, et al. How much lowering of blood pressure is required to prevent cardiovascular disease in patients with and without previous cardiovascular disease? Curr Cardiol Rep. 2022;24(7):851–860. doi:10.1007/s11886-022-01706-4
- Ozkalayci F, Kocabas U, Altun BU, Pandi-Perumal S, Altun A. Relationship between melatonin and cardiovascular disease. Cureus. 2021;13(1). doi:10.7759/cureus.12935
- Givler D, Givler A, Luther PM, et al. Chronic administration of melatonin: physiological and clinical considerations. Neurol Int. 2023;15(1):518–533. doi:10.3390/neurolint15010031